We performed WGS of DNA from the tumor in this case for the first time and identified a nonsense variant of KMT2A. KMT2A plays a key role in regulating gene expression as a transcriptional coactivator, and its mutations have been reported primarily in blood malignancies [22] but not in schwannomas or neurofibromas. This evidence concerns the gene KMT2A and schwannoma.